MICROB-PREDICT

Feeling butterflies in your tummy? 🦋 It’s not just Valentine’s Day - it’s the excitement of @MicrobPredict joining #Bluesky! Find us there for the latest updates and insights. Let’s connect! 🌐 🔗 bsky.app/profile/microb…

Meet @MicrobPredict representatives @JonelTrebicka et al. at #EASLCongress next week and learn more about the project! When: Wednesday 7 May, 14:00-14:30 Where: Track Hub 4, Cirrhosis & Complications More information: easlcongress.eu/2025-track-hub…

Excited for next week's #EASL2025 in Amsterdam! 💬 Don’t miss our Networking Session 📍 EASL Cirrhosis & Complications Track Hub 📅 9. May, 10-10:30h 🧭 Discover findings on immune cell profiling & multi-omics biomarker discovery in patients with decompensated #cirrhosis

1042 people with at risk Steatotic Liver Disease- 38% are reclassified when reassessed in 2 years! Over 60% with MetALD/ALD and 38% with MASLD change subclass SLD is a dynamic spectrum 👉 people should be reassessed- ALCOHOL AND CMRF! cghjournal.org/article/S1542-…

Just out: MICROB-PREDICT members have contributed to the newly published #ClinicalPracticeGuidelines on #TIPS, a procedure to address complications of #cirrhosis patients suffering from #PortalHypertension! 👉 journal-of-hepatology.eu/article/S0168-… @EASLnews @ef_clif @HorizonEU @EuropeLiver

World cafe @MicrobPredict master class in Cologne with lively round table discussions on what we have learned so far from @MicrobPredict research, identifying the gaps and new research projects, also moderated by @DrLAEdwards and Bryan Contreras

💥🥳🏆💥"Terlipressin therapy is associated with increased risk of colonisation with multidrug‐resistant bacteria in patients with decompensated cirrhosis" surpassed 1,000 views on Wiley Online Library. Thanks to all those who have engaged with this work! doi.org/10.1111/apt.17…

12th Steering Committee Meeting taking place on 26-27 Sept @LUMC_Leiden hosted by @MinnekeC. We are discussing 23 papers on MICROB-PREDICT results about different #ACLF related topics all close to submission to high impact journals. @EASLnews @EuropeLiver @MEDB_LAB @ef_clif

Take this brief survey to tell us where else you might need help in your daily research routine: docs.google.com/forms/d/e/1FAI… #sciencecommunication #projectmanagement #conferenceservices #websitedesign #websitedevelopment #videoproduction #Masterclasses #ScientificWriting #Editing

Congrats, @MinnekeC! What an accomplishment 🌟🤩💫

⏰Publication alert! Self-reported alcohol intake, PEth and CDT all predicted hepatic decompensation and death. However, PEth is superior in predicting liver complications and outcomes in patients with MetALD and ALD. sciencedirect.com/science/articl… @IsraelsenMads @Emil_deleuran

📣 Exciting news: the first two patients have been succesfully included in the ALB-TRIAL in both study sites in the Netherlands! Congratulations to our colleagues of @LUMC_Leiden and @alrijne, to many more inclusions! 📈 #cirrhosis #ALBTrial #MicrobPredict

Here's our next early-career scientist rockstar🎸on @YouTube 📽: youtu.be/fSGujwbYGxI 👉Camila Alvarez-Silva (@mariacalvarezs1) presents 1st results of a multi-#omics study to identify #biomarkers for early identification of Pre-#ACLF patients! @ef_clif @microbiomix @EU_HaDEA

Sound on for this brief promo clip of our new results video on @YouTube! ▶️: youtu.be/0LHVANYGwWU 🤘What do @PeterTreit & Vinnie Moore🎸have in common? They are both rock stars - each in their domain. Check it out! #ACLF #biomarkers #omics @ef_clif @MPI_Biochem @EU_HaDEA

🔈 BIG NEWS! We’ve enrolled the first patient at Hôpital Beaujon, Clichy, France in the #COMBATtrial, a multicenter, randomized, open-label, #PhaseII #clinicaltrial. Read more in our press release: decision-for-liver.eu/wp-content/upl… #LiverTwitter @RautouE @ef_clif @EASLnews

“#Microbiome can predict outcome and decompensation in #liver #cirrhosis.” Peer Bork today at the #IHMCCongress 2024. @BorkLab @embl @JonelTrebicka @HadrichDirk @EU_Commission @EuropeLiver @EASLnews @EU_Health @MB_Insights @ef_clif

Come and check out the poster from @PeterTreit on “Integrated Metagenomic-Metaproteomic Pipeline for Biomarker Discovery in Acute-on-Chronic Liver Failure” at the #IHMCCongress2024 today in Rome. @labs_mann @MPI_Biochem @EuropeLiver

Benjamin Lelouvier from @Vaiomer explains at the #IHMCCongress2024: “Our MUCOSA-PREDICT cohort of late-stage #LiverDisease patients is likely the most comprehensively #microbiome-characterized cohort to date.” @EASLnews @microbiome @WMicrobiomeDay @MicrobiomeDaily @EuropeLiver

Today at the #IHMCCongress2024 (fltr): @SaeedShoaie, Benjamin Lelouvier, @JonelTrebicka, Peer Bork and @DrLAEdwards explaining prediction power of MICROB-PREDICT. @BorkLab @Vaiomer @MEDB_LAB @EASLnews @EuropeLiver @EU_Commission @EU_HaDEA @microbiome @MicrobiomeDaily @ef_clif